The Retail Pharmacy Shake-Up: What’s Happening and Why It Matters

Over the past five years, the U.S. has lost 11% of its retail pharmacies, creating pharmacy deserts that now affect 45 million people. While CVS and Walgreens once expanded aggressively, they are now scaling back, closing thousands of locations in response to rising costs, pricing pressures, and shifting consumer behavior.

 Key insights from the report:

  • 7,000+ pharmacies closed since 2019, with independent stores hit the hardest.
  • Lower reimbursement rates & e-commerce competition are squeezing margins.
  • CVS retains market share despite closures, while Walgreens struggles.
  • The industry is moving from consolidation to rationalization, reshaping how Americans access medications.

Loader Loading…
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

More Popular Posts

Decoding the Digital Landscape: Your Go-To Guide for Independent Consulting Platforms

Oncology and Biotechnology: Driving the Future of Pharmaceutical R&D Spending

Explore Latest

Discover more topics

The Retail Pharmacy Shake-Up: What’s Happening and Why It Matters

Over the past five years, the U.S. has lost 11% of its retail pharmacies, creating pharmacy deserts that now affect 45 million people.

Read More

Decoding the Digital Landscape: Your Go-To Guide for Independent Consulting Platforms

This guide offers a curated list of all major platforms for independent consultants, segmented by key factors like specialization, engagement model, and pricing.

Read More

Oncology and Biotechnology: Driving the Future of Pharmaceutical R&D Spending

This report analyzes current global pharmaceutical R&D, focusing on high investment levels, the concentration of activity in the US and China, and the specific emphasis on oncology and biotechnology.

Read More